Skip to content

Clinical trials

Active, not recruiting Phase 1/2 Cardiovascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 1/2 Status: Active, not recruiting Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
4D Molecular Therapeutics1
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)1
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases3
Vascular Diseases2
Blood Protein Disorders1
Brain Diseases, Metabolic1
Central Nervous System Diseases1
Cerebral Small Vessel Diseases1
Cerebrovascular Disorders1
Dendritic Cell Sarcoma, Interdigitating1
Fabry Disease1
Genetic Diseases, Inborn1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.